Backed by increasingly advanced digital systems and high-quality data that is  ideal for machine learning and artificial intelligence applications, the health industry  is nearing  the trillion-dollar mark.  Given this, the big tech universe is mobilising its resources to build models to develop drugs by simulating their effectiveness on digital twins of patients, to study diseases based on mass data, to manage the hospital and pharmaceutical supply chain, and to monitor patients remotely.

This means that AI, machine learning, and big data are pivotal to this revolution, providing industries ranging from pharmaceuticals to clinical and biomedical with clinical records  of a size and quality  that was unimaginable until a few years ago. The capacity for analysis and statistical calculation now available is revolutionising the way research is carried out.

Corriere delle Comunicazioni talks about the future challenges the industry is facing  and the big tech brands that are most prominent in this emerging market. Click here fo the complete article.